What is the level of liabilities of Xencor this year?
Xencor has a debt balance of 283.9 M USD this year.
Xencor Liabilities 2024
Xencor Liabilities
283.9 M USD
Ticker
XNCR
ISIN
US98401F1057
WKN
A1W96L
In 2024, Xencor's total liabilities amounted to 283.9 M USD, a 138.97% difference from the 118.8 M USD total liabilities in the previous year.
Xencor Aktienanalyse
What does Xencor do?
The company Xencor Inc was founded in 1997 and has since become a significant biotechnology company specializing in the development of therapeutic proteins. Xencor's goal is to develop innovative and tailored therapies for the treatment of serious diseases such as cancer and autoimmune diseases. The company is headquartered in Monrovia, California, and employs a growing number of scientists, engineers, and other professionals specialized in the development of new themes and products. Xencor has acquired a variety of patents over the years to protect its intellectual property. Its business model is based on the development of new therapeutics through its proprietary XmAb technology platform, which enables the production of highly specific polyclonal antibodies that can improve the efficiency and safety of disease treatments. Xencor has divided its business activities into various divisions, including the development of immuno-oncology products, autoimmune therapies, and new methods for the therapy of inflammatory bowel diseases. The company has developed a wide range of products, including a new class of therapeutic antibodies that mobilize and strengthen patients' own immune system to fight cancer cells. By combining these antibodies with other therapies, the effectiveness of the treatment can be further increased. In the autoimmune diseases division, Xencor has developed new therapeutics to better regulate patients' immune system and treat dangerous autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, or lupus. Another focus of the company is the development of therapies for inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. By developing specific antibodies involved in the inflammatory processes in the intestine, Xencor can contribute to improving the treatment of these conditions. Xencor aims to accelerate the development of new therapeutics while improving their efficacy and safety. With the help of its proprietary XmAb technology platform, the company is able to develop new drugs faster and more effectively than conventional methods. Through the combination of technology, research and development, and a high level of commitment, Xencor pursues its vision and has successfully established itself as one of the leading companies in the biotechnology industry. Xencor ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Xencor's Liabilities
Xencor's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Xencor's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Xencor's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Xencor's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Xencor’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Xencor stock
What were the liabilities of Xencor compared to the previous year?
The liabilities of Xencor have increased by 138.97% increased compared to the previous year.
What are the consequences of high debt for investors of Xencor?
High liabilities can pose a risk for investors of Xencor, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Xencor?
Low liabilities mean that Xencor has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Xencor affect the company?
An increase in liabilities of Xencor can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Xencor affect the company?
A decrease in the liabilities of Xencor can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Xencor?
Some factors that can influence the liabilities of Xencor include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Xencor so important for investors?
The liabilities of Xencor are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Xencor take to modify the liabilities?
To change its liabilities, Xencor can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Xencor pay?
Over the past 12 months, Xencor paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xencor is expected to pay a dividend of 0 USD.
What is the dividend yield of Xencor?
The current dividend yield of Xencor is .
When does Xencor pay dividends?
Xencor pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Xencor?
Xencor paid dividends every year for the past 0 years.
What is the dividend of Xencor?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Xencor located?
Xencor is assigned to the 'Health' sector.
Wann musste ich die Aktien von Xencor kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Xencor from 8/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/26/2024.
When did Xencor pay the last dividend?
The last dividend was paid out on 8/26/2024.
What was the dividend of Xencor in the year 2023?
In the year 2023, Xencor distributed 0 USD as dividends.
In which currency does Xencor pay out the dividend?
The dividends of Xencor are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Xencor stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Xencor
Our stock analysis for Xencor Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xencor Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
